1-12 of 12
Aref Al-Kali
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

T-cell immune cluster analysis using CyTOF identifies unique subgroups of patients with acute myeloid leukemia.

Clinical Trials & Observations
Talha Badar, Keith Knutson, James M Foran, Naseema Gangat, Kevin D Pavelko, Scott H Kaufmann, Mark R Litzow, Hemant S. Murthy, Davitte Cogen, Margaret Ushman, Arini Arsana, Aref Al-Kali, Hassan B Alkhateeb, Ayalew Tefferi, Mrinal M. Patnaik, Mithun Vinod Shah
Journal: Blood Advances
Blood Adv bloodadvances.2024014553.
https://doi.org/10.1182/bloodadvances.2024014553
Published: 2024
Includes: Supplemental data
Journal Articles

Molecular and clinical characterization of ETNK1 -mutated myeloid neoplasms: the Mayo Clinic experience

Steven Tessier, Rong He, Patricia Greipp, David Viswanatha, Kurt Bessonen, Terra Lasho, James Foran, Cecilia Arana-Yi, Naseema Gangat, Ayalew Tefferi, Mithun Shah, Hassan Alkhateeb, Shujun Liu, Animesh Pardanani, Mrinal Patnaik, Aref Al-Kali
Journal: Blood Advances
Blood Adv (2024) 8 (18): 4807–4811.
https://doi.org/10.1182/bloodadvances.2024013255
Published: 2024
Includes: Supplemental data
Journal Articles

The impact of cytotoxic therapy on the risk of progression and death in clonal cytopenia(s) of undetermined significance

Marissa Li, Anmol Baranwal, Mark Gurney, Syed N. Shah, Aref Al-Kali, Hassan Alkhateeb, James Foran, Cecilia Arana Yi, Laura Ongie, Dong Chen, Abhishek Mangaonkar, Kristen McCullough, Ayalew Tefferi, Terra Lasho, Christy Finke, Mrinal M. Patnaik, Mithun Vinod Shah
Journal: Blood Advances
Blood Adv (2024) 8 (12): 3130–3139.
https://doi.org/10.1182/bloodadvances.2023012357
Published: 2024
Includes: Supplemental data
Journal Articles

Genetic features and outcomes of allogeneic transplantation in patients with WT1 -mutated myeloid neoplasms

Clinical Trials & Observations
Anmol Baranwal, Rami Basmaci, Rong He, David Viswanatha, Patricia Greipp, Hemant S. Murthy, James Foran, Jeanne Palmer, William J. Hogan, Mark R. Litzow, Mehrdad Hefazi, Abhishek Mangaonkar, Mithun Vinod Shah, Aref Al-Kali, Hassan B. Alkhateeb
Journal: Blood Advances
Blood Adv (2024) 8 (3): 562–570.
https://doi.org/10.1182/bloodadvances.2023010960
Published: 2024
Includes: Supplemental data
Journal Articles

Black African-American patients with primary myelofibrosis: a comparative analysis of phenotype and survival

Naseema Gangat, Andrew Kuykendall, Najla Al Ali, Swati Goel, Maymona Abdelmagid, Aref Al-Kali, Hassan B. Alkhateeb, Kebede H. Begna, Abhishek Mangaonkar, Mark R. Litzow, William Hogan, Mithun Shah, Mrinal M. Patnaik, Animesh Pardanani, Rami Komrokji, Ayalew Tefferi
Journal: Blood Advances
Blood Adv (2023) 7 (12): 2694–2698.
https://doi.org/10.1182/bloodadvances.2022009611
Published: 2023
Journal Articles

Clinical and prognostic impact of STAG2 mutations in myeloid neoplasms: the Mayo Clinic experience

Bahga Katamesh, Ahmad Nanaa, Rong He, David Viswanatha, Phuong Nguyen, Patricia Greipp, Kurt Bessonen, Naseema Gangat, Kebede Begna, Abhishek Mangaonkar, Mrinal Patnaik, William J. Hogan, Ayalew Tefferi, Mark Litzow, Mithun Vinod Shah, Cecilia Arana Yi, James Foran, Talha Badar, Hassan B. Alkhateeb, Aref Al-Kali
Journal: Blood Advances
Blood Adv (2023) 7 (8): 1351–1355.
https://doi.org/10.1182/bloodadvances.2022007937
Published: 2023
Includes: Supplemental data
Journal Articles

Cardiac events in patients with acute myeloid leukemia treated with venetoclax combined with hypomethylating agents

Isla M. Johnson, Evandro D. Bezerra, Faiqa Farrukh, Kristen McCullough, Aref Al-Kali, Hassan B. Alkhateeb, Kebede Begna, Mark R. Litzow, William J. Hogan, Mithun Vinod Shah, Mrinal M. Patnaik, Ayalew Tefferi, Naseema Gangat
Journal: Blood Advances
Blood Adv (2022) 6 (17): 5227–5231.
https://doi.org/10.1182/bloodadvances.2022007333
Published: 2022
Includes: Supplemental data
Journal Articles

Genetic features and clinical outcomes of patients with isolated and comutated DDX41 -mutated myeloid neoplasms

Hassan B. Alkhateeb, Ahmad Nanaa, David Viswanatha, James M. Foran, Talha Badar, Lisa Sproat, Rong He, Phuong Nguyen, Dragan Jevremovic, Mohamad E. Salama, Patricia Greipp, Naseema Gangat, Ayalew Tefferi, Mark R. Litzow, Abhishek A. Mangaonkar, Mithun Vinod Shah, Mrinal Patnaik, Aref Al-Kali
Journal: Blood Advances
Blood Adv (2022) 6 (2): 528–532.
https://doi.org/10.1182/bloodadvances.2021005738
Published: 2022
Includes: Supplemental data
Journal Articles

Clinical, molecular, and prognostic comparisons between CCUS and lower-risk MDS: a study of 187 molecularly annotated patients

Clinical Trials & Observations
Marissa Li, Moritz Binder, Terra Lasho, Alejandro Ferrer, Naseema Gangat, Aref Al-Kali, Abhishek Mangaonkar, Michelle Elliott, Mark Litzow, William Hogan, Animesh Pardanani, Alexandra Wolanskyj-Spinner, Matthew Howard, Rebecca L. King, Mithun Shah, Hassan Alkhateeb, Kebede Begna, Ayalew Tefferi, Christy Finke, Jennifer Oliveira, Rhett Ketterling, Horatiu Olteanu, Mrinal M. Patnaik
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2272–2278.
https://doi.org/10.1182/bloodadvances.2020003976
Published: 2021
Includes: Supplemental data
Journal Articles

SF3B1 -mutant CMML defines a predominantly dysplastic CMML subtype with a superior acute leukemia–free survival

Clinical Trials & Observations
Kitsada Wudhikarn, Sanam Loghavi, Abhishek A. Mangaonkar, Aref Al-Kali, Moritz Binder, Ryan Carr, Kaaren Reichard, Christy Finke, Matthew Howard, Naseema Gangat, Ayalew Tefferi, Rami Komrokji, Najla Ali, Terra Lasho, Rhett Ketterling, Eric Padron, Mrinal M. Patnaik
Journal: Blood Advances
Blood Adv (2020) 4 (22): 5716–5721.
https://doi.org/10.1182/bloodadvances.2020003345
Published: 2020
Includes: Supplemental data
Journal Articles

Bone marrow dendritic cell aggregates associate with systemic immune dysregulation in chronic myelomonocytic leukemia

Abhishek A. Mangaonkar, Kaaren K. Reichard, Moritz Binder, Giacomo Coltro, Terra L. Lasho, Ryan M. Carr, April Chiu, Vivian Negron, Mehrdad Hefazi, Theodora Anagnostou, Michael M. Timm, James W. Hiebert, Jose C. Villasboas, Wilson I. Gonsalves, Naseema Gangat, Mithun Shah, Hassan B. Alkhateeb, Aref Al-Kali, Michelle A. Elliott, Kebede H. Begna, Alexandra P. Wolanskyj-Spinner, Mark R. Litzow, William J. Hogan, Stephen M. Ansell, Animesh Pardanani, Ayalew Tefferi, Mrinal M. Patnaik
Journal: Blood Advances
Blood Adv (2020) 4 (21): 5425–5430.
https://doi.org/10.1182/bloodadvances.2020002415
Published: 2020
Includes: Supplemental data
Journal Articles

Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort

Clinical Trials & Observations
Maximilian Stahl, Michelle DeVeaux, Pau Montesinos, Raphael Itzykson, Ellen K. Ritchie, Mikkael A. Sekeres, John D. Barnard, Nikolai A. Podoltsev, Andrew M. Brunner, Rami S. Komrokji, Vijaya R. Bhatt, Aref Al-Kali, Thomas Cluzeau, Valeria Santini, Amir T. Fathi, Gail J. Roboz, Pierre Fenaux, Mark R. Litzow, Sarah Perreault, Tae Kon Kim, Thomas Prebet, Norbert Vey, Vivek Verma, Ulrich Germing, Juan Miguel Bergua, Josefina Serrano, Steven D. Gore, Amer M. Zeidan
Journal: Blood Advances
Blood Adv (2018) 2 (8): 923–932.
https://doi.org/10.1182/bloodadvances.2018016121
Published: 2018
Includes: Supplemental data